|
1
|
McInnes IB and Schett G: The pathogenesis
of rheumatoid arthritis. N Engl J Med. 365:2205–2219. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
McInnes IB and Schett G: Pathogenetic
insights from the treatment of rheumatoid arthritis. Lancet.
389:2328–2337. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Monti S, Montecucco C, Bugatti S and
Caporali R: Rheumatoid arthritis treatment: The earlier the better
to prevent joint damage. RMD Open. 1 (Suppl 1):e0000572015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Stevenson M, Archer R, Tosh J, Simpson E,
Everson-Hock E, Stevens J, Hernandez-Alava M, Paisley S, Dickinson
K, Scott D, et al: Adalimumab, etanercept, infliximab, certolizumab
pegol, golimumab, tocilizumab and abatacept for the treatment of
rheumatoid arthritis not previously treated with disease--modifying
antirheumatic drugs and after the failure of conventional
disease-modifying antirheumatic drugs only: Systematic review and
economic evaluation. Health Technol Assess. 20:1–610. 2016.
View Article : Google Scholar
|
|
5
|
Smolen JS, Breedveld FC, Burmester GR,
Bykerk V, Dougados M, Emery P, Kvien TK, Navarro-Compán MV, Oliver
S, Schoels M, et al: Treating rheumatoid arthritis to target: 2014
update of the recommendations of an international task force. Ann
Rheum Dis. 75:3–15. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Choy EH and Panayi GS: Cytokine pathways
and joint inflammation in rheumatoid arthritis. N Engl J Med.
344:907–916. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Silverstein FE, Faich G, Goldstein JL,
Simon LS, Pincus T, Whelton A, Makuch R, Eisen G, Agrawal NM,
Stenson WF, et al: Gastrointestinal toxicity with celecoxib vs
nonsteroidal anti-inflammatory drugs for osteoarthritis and
rheumatoid arthritis: The CLASS study: A randomized controlled
trial. celecoxib long-term arthritis safety study. JAMA.
284:1247–1255. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pickens SR, Volin MV, Mandelin AM II,
Kolls JK, Pope RM and Shahrara S: IL-17 contributes to angiogenesis
in rheumatoid arthritis. J Immunol. 184:3233–3241. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Song J, Kim D, Han J, Kim Y, Lee M and Jin
EJ: PBMC and exosome-derived Hotair is a critical regulator and
potent marker for rheumatoid arthritis. Clin Exp Med. 15:121–126.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang KY and Chen DL: Shikonin inhibits
inflammatory response in rheumatoid arthritis synovial fibroblasts
via lncRNA-NR024118. Evid Based Complement Alternat Med.
2015:6317372015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pei Z, Du X, Song Y, Fan L, Li F, Gao Y,
Wu R, Chen Y, Li W, Zhou H, et al: Down-regulation of lncRNA CASC2
promotes cell proliferation and metastasis of bladder cancer by
activation of the Wnt/β-catenin signaling pathway. Oncotarget.
8:18145–18153. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cao Y, Xu R, Xu X, Zhou Y, Cui L and He X:
Downregulation of lncRNA CASC2 by microRNA-21 increases the
proliferation and migration of renal cell carcinoma cells. Mol Med
Rep. 14:1019–1025. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lee SY, Kwok SK, Son HJ, Ryu JG, Kim EK,
Oh HJ, Cho ML, Ju JH, Park SH and Kim HY: IL-17-mediated Bcl-2
expression regulates survival of fibroblast-like synoviocytes in
rheumatoid arthritis through STAT3 activation. Arthritis Res Ther.
15:R312013. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang Y, Xu YZ, Sun N, Liu JH, Chen FF,
Guan XL, Li A, Wang F, Zhao QF, Wang HY, et al: Long noncoding RNA
expression profile in fibroblast-like synoviocytes from patients
with rheumatoid arthritis. Arthritis Res Ther. 18:2272016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Huang XD, Dai JG, Lin KT, Liu M, Ruan HT,
Zhang H, Liu WG, He MX and Zhao M: Regulation of IL-17 by lncRNA of
IRF-2 in the pearl oyster. Fish Shellfish Immunol. 81:108–112.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huang W, Thomas B, Flynn RA, Gavzy SJ, Wu
L, Kim SV, Hall JA, Miraldi ER, Ng CP, Rigo F, et al: DDX5 and its
associated lncRNA Rmrp modulate TH17 cell effector functions.
Nature. 528:517–522. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bartok B and Firestein GS: Fibroblast-like
synoviocytes: Key effector cells in rheumatoid arthritis. Immunol
Rev. 233:233–255. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zou S, Wang C, Cui Z, Guo P, Meng Q, Shi
X, Gao Y, Yang G and Han Z: β-Elemene induces apoptosis of human
rheumatoid arthritis fibroblast-like synoviocytes via reactive
oxygen species-dependent activation of p38 mitogen-activated
protein kinase. Pharmacol Rep. 68:7–11. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li S, Jin Z and Lu X: MicroRNA-192
suppresses cell proliferation and induces apoptosis in human
rheumatoid arthritis fibroblast-like synoviocytes by downregulating
caveolin 1. Mol Cell Biochem. 432:123–130. 2017. View Article : Google Scholar : PubMed/NCBI
|
